Unraveling the microbiome's role in breast cancer progression and treatment response [0.03%]
揭秘微生物组在乳腺癌进展和治疗反应中的作用
Anmar Ghanim Taki,Abdulkareem Shareef,Vimal Arora et al.
Anmar Ghanim Taki et al.
The human microbiome, encompassing microbial communities in the gut and breast tissue, has emerged as a critical modulator of breast cancer (BC) initiation, progression, and treatment response. This review synthesizes current evidence on th...
Efficacy and safety of immunotherapy combined with chemotherapy in both neoadjuvant and adjuvant settings among triple-negative breast cancer: A meta-analysis of randomized clinical trials [0.03%]
免疫治疗联合化疗在三阴性乳腺癌新辅助及辅助治疗中的疗效和安全性：随机临床试验的meta分析
Jingru Han,Simeng Gao,Man Li et al.
Jingru Han et al.
This meta-analysis evaluated the efficacy and safety of combining immune checkpoint inhibitors (ICIs) with chemotherapy in triple-negative breast cancer (TNBC). We systematically searched PubMed, Embase, and the Cochrane Library for randomi...
Contribution of BARD1 gene to male breast cancer- report of a family with different types of cancer [0.03%]
BARD1基因与男性乳腺癌的关系——一具有不同癌症类型的家族病例报告
Akram Sarmadi,Shaghayegh Haghjooy Javanmard,Mehrdad Zeinalian et al.
Akram Sarmadi et al.
Background: Breast cancer (BC) arises from a combination of genetic and environmental factors, continues to be the leading cause of cancer-related mortality among women. Although male BC accounts for
Angiogenesis biomarkers in prostate cancer: Unlocking new avenues for prognosis and diagnosis [0.03%]
前列腺癌的血管生成生物标志物：解锁新的预后和诊断途径
Büşra Ecer,Abdullah Sivrikaya,Gökhan Ecer et al.
Büşra Ecer et al.
Objective: To evaluate the levels of angiogenesis-related biomarkers, including Thrombospondin-1 (TSP1), Endostatin, Osteopontin, and Tumstatin, in prostate cancer patients and their relationship with tumor spread and cli...
MRI-fusion biopsy era: the role of perineural invasion in low-risk prostate cancer [0.03%]
融合MRI活检时代的低位前列腺癌的神经周围浸润作用分析
Nethusan Sivanesan,Gabriela M Diaz,Sebastien Strachan et al.
Nethusan Sivanesan et al.
Objective: To evaluate whether perineural invasion independently predicts Gleason score upgrading during active surveillance in patients undergoing MRI-US fusion biopsy. ...
Current perspectives on Lifileucel tumor-infiltrating lymphocyte therapy: A paradigm shift in immunotherapy [0.03%]
肺癌淋巴细胞浸润免疫治疗的现状及前景：一场免疫治疗领域的革新
Simran Deep Kaur,Md Abubakar,Neena Bedi et al.
Simran Deep Kaur et al.
Lifileucel, a tumor-infiltrating lymphocyte (TIL) therapy, provides renewed hope for individuals with advanced, treatment-resistant malignancies. This is a groundbreaking advancement in cancer immunotherapy. Revolutionizing the way the immu...
A phase prospective trial of re-irradiation of locally recurrent or second primary head and neck tumors using stereotactic body radiation therapy [0.03%]
立体定向体放射治疗重辐射局部复发或第二原发头颈部肿瘤的期前瞻性试验
Sally Fouda,Tarek Hamed Shouman,Ashraf Hamed Hassouna et al.
Sally Fouda et al.
Objective: To assess SBRT in the reirradiation of head and neck (H&N) cancers. Patients and methods: 30 patients with 31 sites received...
Clinical characteristics and treatment analysis of pulmonary blastoma (PB): a report of 17 cases [0.03%]
肺blastoma(PB)的临床特征及治疗分析(17例报告)
Jiaqi Guan,Jinglai Sun,Zhiping Hu et al.
Jiaqi Guan et al.
Introduction: To summarize the disease characteristics of pulmonary blastoma, analyze related prognostic factors, and share the diagnosis and treatment process. ...
Hormone replacement therapy in endometrial cancer survivors: A retrospective cohort study on recurrence, survival, and quality of life [0.03%]
雌激素替代治疗对子宫内膜癌幸存者的影响：一项关于复发、生存率和生活质量的回顾性队列研究
Jiali Xing,Qi Liu,Li Qiao
Jiali Xing
Background: Endometrial cancer is the most common gynecologic malignancy in developed countries, often affecting postmenopausal women but also seen in younger patients. Standard treatment includes hysterectomy with bilate...
Efficacy and safety of toripalimab in treating nasopharyngeal carcinoma: A meta-analysis [0.03%]
特瑞普利单抗治疗鼻咽癌疗效和安全性的meta分析研究
Yiwei Sun,Lingqin Kong
Yiwei Sun
Purpose: To systematically assess the effectiveness and safety of toripalimab in the treatment of nasopharyngeal carcinoma (NPC) based on clinical trial reports. ...